Send the following on WhatsApp
Continue to ChatABBV-RGX-314 : REGENXBIO reports positive Phase 2 data on diabetic retinopathy gene therapy candidate https://business-news-today.com/abbv-rgx-314-regenxbio-reports-positive-phase-2-data-on-diabetic-retinopathy-gene-therapy-candidate/